Andrew Cleland has worked at Time Warner for nearly a decade, five years of which has been in corporate venturing, and is now opening Comcast Interactive Capital’s Manhattan office.
Month: March 2011
AMS finds its NxThera
American Medical Systems joins consortium investing $12.6m in US-based peer NxThera.
CoolPlanetBioFuels extends B round
Google Ventures extends CoolPlanetBioFuels B round to about $20m.
Pricelock adds $12m
The consortium backing Pricelock’s $12m B round includes banks Goldman Sachs and Barclays, insurers RenaissanceRe’s corporate venturing unit RenaissanceRe Ventures and Travelers Insurance, and venture capital firm Artiman Ventures.
Waste Management adds to its harvest
Waste Management had previously invested in Harvest Power in January last year, a month after a regulatory filing said the portfolio company closed a $10m round.
Qihoo turns circle with US listing
Investment banks UBS and Citi are leading underwriters of IDG-backed Qihoo’s initial public offering.
Apache designs Nasdaq flotation
Intel Capital owns 6.4% of Apache Design Solutions having originally invested in 2001 as part of a marketing agreement and ahead of its US listing.
LivingSocial acquires InfoEther
InfoEther is a technology consultancy specialising in the open source Ruby software development language and its related web development framework, Ruby on Rails, which is the basis of the technology upon which LivingSocial is based.
Jiangsu Holly sets up fund
Jiangsu Hongrui will be managed by Jiangsu Holly jointly with Jiangsu Holly Futures Brokerage, Jiangsu Hezhong Venture Capital, Jiangsu Kaiyuan Venture Capital, Shanghai Jingaofu Equity Investment and other individuals, according to news provider 163.com.
HomeAway prepares for listing
HomeAway’s flotation will be managed by investment banks Morgan Stanley, Deutsche Bank, JPMorgan Chase and Goldman Sachs, according to its regulatory filing.
Solazyme plans $100m flotation
Solazyme, a US-based developer of biofuels through the use of algae, said it had raised $129.3m in equity and its strategic investors were Bunge, Chevron, Unilever and San-Ei Gen ahead of its $100m flotation.
Edwards buys Embrella Cardiovascular
Embrella raised $6.7m in its series B round in August 2008 from New York-listed medical device maker Edwards Lifesciences and venture capital firms BioStar Ventures, MedFocus Fund and Hatteras Venture Partners.
Intel crosses into Altobridge
Intel Capital joins consortium investing $12m in Altobridge.
VigLink searches for Google
Venture capital (VC) firm Emergence Capital led the B round in VigLink as a new investor and was joined by Google Ventures and VC firm First Round Capital. VigLink has now raised $7.3m since it started.